IN2013CN02996A - - Google Patents
Download PDFInfo
- Publication number
- IN2013CN02996A IN2013CN02996A IN2996CHN2013A IN2013CN02996A IN 2013CN02996 A IN2013CN02996 A IN 2013CN02996A IN 2996CHN2013 A IN2996CHN2013 A IN 2996CHN2013A IN 2013CN02996 A IN2013CN02996 A IN 2013CN02996A
- Authority
- IN
- India
- Prior art keywords
- desmosterol
- disease
- alzheimer
- cognitive impairment
- mild cognitive
- Prior art date
Links
- BDCFUHIWJODVNG-UHFFFAOYSA-N Desmosterol Natural products C1C=C2CC(O)C=CC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 BDCFUHIWJODVNG-UHFFFAOYSA-N 0.000 abstract 4
- 208000010877 cognitive disease Diseases 0.000 abstract 4
- AVSXSVCZWQODGV-DPAQBDIFSA-N desmosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCC=C(C)C)C)[C@@]1(C)CC2 AVSXSVCZWQODGV-DPAQBDIFSA-N 0.000 abstract 4
- 201000010099 disease Diseases 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 208000027061 mild cognitive impairment Diseases 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 102000013455 Amyloid beta-Peptides Human genes 0.000 abstract 2
- 108010090849 Amyloid beta-Peptides Proteins 0.000 abstract 2
- 102000004878 Gelsolin Human genes 0.000 abstract 2
- 108090001064 Gelsolin Proteins 0.000 abstract 2
- 239000000090 biomarker Substances 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/203332—Hydroxyl containing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010235203 | 2010-10-20 | ||
| US201061424885P | 2010-12-20 | 2010-12-20 | |
| JP2010282938 | 2010-12-20 | ||
| PCT/JP2011/064487 WO2012053255A1 (ja) | 2010-10-20 | 2011-06-23 | アルツハイマー病又は軽度認知症のバイオマーカー |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013CN02996A true IN2013CN02996A (https=) | 2015-08-14 |
Family
ID=45974981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2996CHN2013 IN2013CN02996A (https=) | 2010-10-20 | 2011-06-23 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9581604B2 (https=) |
| EP (1) | EP2631646B1 (https=) |
| JP (1) | JP5695075B2 (https=) |
| AU (1) | AU2011319319B2 (https=) |
| BR (1) | BR112013009592A2 (https=) |
| CA (1) | CA2814385C (https=) |
| IN (1) | IN2013CN02996A (https=) |
| NZ (1) | NZ609324A (https=) |
| RU (1) | RU2563987C2 (https=) |
| WO (1) | WO2012053255A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201212084D0 (en) * | 2012-07-06 | 2012-08-22 | Randox Lab Ltd | Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment |
| EP3267200A4 (en) * | 2015-03-06 | 2018-08-22 | Niigata University | Biomarker of dementia with lewy bodies |
| ES2657414T3 (es) * | 2015-11-20 | 2018-03-05 | Geroa Diagnostics, S.L | Uso de la lactoferrina en el diagnóstico o el pronóstico de la enfermedad de Alzheimer |
| CN114410774A (zh) * | 2022-02-17 | 2022-04-29 | 杭州怡健医疗科技有限公司 | 一种应用于阿尔茨海默氏症的患病风险评估方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003088811A2 (en) * | 2002-04-16 | 2003-10-30 | The Brigham And Women's Hospital, Inc. | Gelsolin as a prognostic marker of artherosclerotic diseases |
| JPWO2007097461A1 (ja) * | 2006-02-27 | 2009-07-16 | 国立大学法人 熊本大学 | Ｃ型肝炎治療用抗体 |
| US7645748B2 (en) * | 2006-04-03 | 2010-01-12 | Forbes Medi-Tech Inc. | Sterol/stanol phosphorylnitroderivatives and use thereof |
| RU2356058C2 (ru) * | 2006-11-27 | 2009-05-20 | Александр Васильевич Мальцев | Способ диагностики амилоидоза при болезни альцгеймера и комплект средств для его осуществления |
-
2011
- 2011-06-23 CA CA2814385A patent/CA2814385C/en not_active Expired - Fee Related
- 2011-06-23 BR BR112013009592A patent/BR112013009592A2/pt not_active Application Discontinuation
- 2011-06-23 AU AU2011319319A patent/AU2011319319B2/en not_active Ceased
- 2011-06-23 US US13/880,475 patent/US9581604B2/en not_active Expired - Fee Related
- 2011-06-23 JP JP2012539625A patent/JP5695075B2/ja not_active Expired - Fee Related
- 2011-06-23 IN IN2996CHN2013 patent/IN2013CN02996A/en unknown
- 2011-06-23 RU RU2013122853/15A patent/RU2563987C2/ru not_active IP Right Cessation
- 2011-06-23 WO PCT/JP2011/064487 patent/WO2012053255A1/ja not_active Ceased
- 2011-06-23 EP EP11834097.5A patent/EP2631646B1/en active Active
- 2011-06-23 NZ NZ609324A patent/NZ609324A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2814385C (en) | 2017-10-24 |
| WO2012053255A1 (ja) | 2012-04-26 |
| AU2011319319A1 (en) | 2013-05-02 |
| NZ609324A (en) | 2014-09-26 |
| EP2631646B1 (en) | 2016-10-19 |
| US20130266589A1 (en) | 2013-10-10 |
| BR112013009592A2 (pt) | 2016-07-12 |
| US9581604B2 (en) | 2017-02-28 |
| JP5695075B2 (ja) | 2015-04-01 |
| RU2013122853A (ru) | 2014-11-27 |
| CA2814385A1 (en) | 2012-04-26 |
| EP2631646A1 (en) | 2013-08-28 |
| EP2631646A4 (en) | 2014-05-07 |
| AU2011319319B2 (en) | 2015-07-30 |
| RU2563987C2 (ru) | 2015-09-27 |
| JPWO2012053255A1 (ja) | 2014-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013022493A2 (pt) | equipamento e método para examinar, diagnosticar ou auxiliar no diagnóstico e no tratamento de problemas funcionais de visão | |
| EA201400491A1 (ru) | Сопровождающая диагностика для терапии с антигиалуроновым агентом и способы ее применения | |
| WO2011064225A8 (en) | Novel diagnostic method for the diagnosis of alzheimer's disease or mild cognitive impairment | |
| EP2539470A4 (en) | DIAGNOSIS, PROGNOSIS AND TREATMENT PROCEDURE FOR AUTOIMMUNE DISEASES | |
| WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
| EP2134855A4 (en) | USES OF FANCI AND FANCI MODULATING AGENTS IN PROGNOSIS, DIAGNOSIS AND CANCER THERAPY | |
| WO2012031008A3 (en) | Cancer-related biological materials in microvesicles | |
| SG179095A1 (en) | Novel assay for the detection of amyloid beta peptides | |
| EP2652498A4 (en) | DIAGNOSIS AND TREATMENTS ASSOCIATED WITH TH2 INHIBITION | |
| BR112014018592A2 (pt) | composição e método para o diagnóstico e tratamento de doenças associadas à degeneração de neuritos | |
| EP2569630A4 (en) | DIAGNOSTIC AUTOANTIKÖRPER PROFILES FOR THE DETECTION AND DIAGNOSIS OF NEURODEGENERATIVE DISEASES | |
| WO2014036495A3 (en) | Diagnostic assays and kits for detection of folate receptor 1 | |
| IL258794B (en) | Methods and compositions for diagnosis and treatment of cancer | |
| EP2903597A4 (en) | USE OF MICROVESICLES IN THE DIAGNOSIS, FORECAST AND TREATMENT OF DISEASES AND MEDICAL SUDDEN | |
| WO2016040891A3 (en) | In vitro compositions comprising human sample and amyloid targeting agent | |
| EP2547397A4 (en) | SYSTEM FOR DIAGNOSIS AND TREATMENT OF DIABETES SYMPTOMS | |
| EP2260107A4 (en) | TESTS FOR THE DIAGNOSIS AND ASSESSMENT OF TREATMENT OPTIONS FOR MORBUS POMPE | |
| BR112013016107A2 (pt) | molécula dimérica, método de tratamento de câncer, composição farmacêutica e kit para o diagnóstico de uma patologia ou tumor mediado(a) por upar | |
| IT1400684B1 (it) | Metodo e dispositivo di imaging per il monitoraggio di un corpo in esame. | |
| EP2361317A4 (en) | USE OF EIF3M FOR THE DIAGNOSIS AND TREATMENT OF CANCER | |
| BRPI0921140A2 (pt) | sistema e método de diagnóstico de doenças em bovinos usando análise de auscuta | |
| WO2012075023A3 (en) | Neoantibodies for diagnosing tissue injury | |
| WO2013164763A3 (en) | A biological complex specific for alzheimer's disease detection in vitro and use thereof | |
| MX385216B (es) | Prueba de diagnostico basada en fragmento de rgma. | |
| IN2013CN02996A (https=) |